Dedifferentiated liposarcoma (DDLS) is a rare and aggressive soft tissue cancer with few effective treatment options. But now a clinical trial led by doctors from Memorial Sloan K ...

New bowel cancer drug halts tumour growth in nine out of 10 patients - The drug works by triggering the ‘death’ of cancer ...

Targeted drug shows promise for people with advanced bowel cancer in early trial - One patient taking part in the trial said the therapy has given her a ‘new lease of life’.

Thirty-two people walked into a London hospital with operable bowel cancer. They received nine weeks of a single immunotherapy drug, pembrolizumab, before undergoing surgery. Nearly three years later, ...

A pioneering blood test that can detect more than 50 cancers before symptoms appear could save tens of thousands of lives a year, promising new research suggests. Results of an NHS-backed trial show ...

Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We conducted a ...